ALLORION THERAPEUTICS
Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses. Allorion operates two locations in Natick, Massachusetts, and Guangzhou, China.
ALLORION THERAPEUTICS
Industry:
Medical Pharmaceutical Therapeutics
Founded:
2020-01-01
Address:
Natick, Massachusetts, United States
Country:
United States
Website Url:
http://www.alloriontx.com
Total Employee:
11+
Status:
Active
Total Funding:
90 M USD
Technology used in webpage:
CrUX Dataset CrUX Top 10m
Similar Organizations
1E Therapeutics
1E Therapeutics is a breakthrough, drug development company.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Aristea Therapeutics
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
CS MEDICA
CS MEDICA is a Medical Equipment Manufacturing and distribution of OTC CBD medical devices and cosmetics company.
Optio RX
Optio RX is an owner and operator of specialty compounding pharmacies and home infusion provider.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Current Advisors List
Board_member
Current Employees Featured
Qiang Ding Founder and CEO @ Allorion Therapeutics
Founder and CEO
Founder
Investors List
3SBio Inc.
3SBio Inc. investment in Series B - Allorion Therapeutics
LongRiver Investments
LongRiver Investments investment in Series B - Allorion Therapeutics
Elikon Venture
Elikon Venture investment in Series B - Allorion Therapeutics
TF Capital
TF Capital investment in Series B - Allorion Therapeutics
Octagon Capital
Octagon Capital investment in Series B - Allorion Therapeutics
INCE Capital
INCE Capital investment in Series B - Allorion Therapeutics
Qiming Venture Partners
Qiming Venture Partners investment in Series B - Allorion Therapeutics
Octagon Capital Advisors
Octagon Capital Advisors investment in Series A - Allorion Therapeutics
Firstred Capital
Firstred Capital investment in Series A - Allorion Therapeutics
Elikon Venture
Elikon Venture investment in Series A - Allorion Therapeutics
Official Site Inspections
http://www.alloriontx.com Semrush global rank: 5.45 M Semrush visits lastest month: 1.36 K
- Host name: 244.42.212.35.bc.googleusercontent.com
- IP address: 35.212.42.244
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Allorion Therapeutics"
Home - Allorion Therapeutics
Upholding a science- and data-driven R&D strategy, Allorion is developing globally competitive drugs to address the unmet needs of patients by leveraging its highly innovative discovery …See details»
Allorion Therapeutics - Crunchbase Company Profile
Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.See details»
Allorion Therapeutics
About Us At Allorion Therapeutics, we focus on developing novel small molecule drugs against cancer and autoimmune diseases. Our team is comprised of experts in cancer biology and …See details»
Our Team - Allorion Therapeutics
Seasoned Leaders in the Field Our team We are an exceptional team of leaders committed to driving transformative advancements in drug development. Leadership Peter Ding Chief …See details»
Allorion Therapeutics - LinkedIn
Allorion Therapeutics | 1,809 followers on LinkedIn. The next-generation targeted drugs for human diseases | At Allorion Therapeutics, we focus on developing novel small molecule drugs …See details»
Allorion Therapeutics Company Profile | Management and
Find contact information for Allorion Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and Allorion Therapeutics's email format.See details»
Allorion Therapeutics Overview | SignalHire Company Profile
Summary At Allorion Therapeutics, we focus on developing novel small molecule drugs against cancer and autoimmune diseases. Our team is comprised of experts in cancer biology and …See details»
Allorion Therapeutics Guangzhou - life-sciences-asia.com
Nov 24, 2021 Allorion Therapeutics is a biotechnology company that focuses on creating new small molecule drugs for treating cancer and autoimmune diseases. The company has a team …See details»
Allorion Therapeutics - VentureRadar
"At Allorion Therapeutics, we focus on developing novel small molecule drugs against cancer and autoimmune diseases. Our team is comprised of experts in cancer biology and drug …See details»
Allorion Therapeutics 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Allorion Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Overview - Allorion Therapeutics
First-in-Class Therapeutics Overview Allorion Therapeutics is a biotechnology company that focuses on creating new small molecule drugs for treating cancer and autoimmune diseases. Our Vision We envision a future where targeted …See details»
Overview, News & Similar companies - ZoomInfo.com
Jan 1, 2024 View Allorion Therapeutics (www.alloriontx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Mission, Vision & Core Values of Allorion Therapeutics
Dec 19, 2024 Allorion Therapeutics is dedicated to revolutionizing the field of biotechnology through our unwavering commitment to innovation, excellence, and integrity. Our mission is to …See details»
Allorion Therapeutics Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Allorion Therapeutics. See Allorion Therapeutics company profile and funding data.See details»
Allorion Therapeutics - plugeln.alloriontx.com
Allorion Therapeutics, a company focusing on next-generation precision medicine for oncology and autoimmune disease, today announced that Dr. Gregory Berk has joined the company as …See details»
Allorion Therapeutics Announces Exclusive Option and Global …
NATICK, Mass., Jan. 2, 2024 /PRNewswire/ -- Allorion Therapeutics ("Allorion"), a US and China-based biotechnology company that focuses on the discovery of new small molecule drugs for …See details»
Chief Medical Officer - Allorion Therapeutics
We seek a highly motivated and experienced leader as the Chief Medical Officer to advance Allorion’s programs. The successful candidate will be a key member of the Allorion leadership …See details»
Contact - Allorion Therapeutics
Keep in Touch Contact Interested in learning more about Allorion Therapeutics? Please reach out today! 42.29792, -71.38259 22 Strathmore Road, Natick, MA 01760, USA 23.15714, …See details»
Allorion Therapeutics - plugeln.alloriontx.com
Allorion Therapeutics, a company focusing on next-generation precision medicine for oncology and autoimmune disease, announces the completion of a $50 million Series B financing round, …See details»
News - Allorion Therapeutics
Latest Updates & Insights News Trace the advancements of Allorion Therapeutics through the years News sorted by year 2024 January 4, 2024 Avenzo Therapeutics announces global …See details»